RAPT Therapeutics (RAPT) Investor Presentation - Slideshow

Transforming the Treatment of Cancer and Inflammation March 2020 Corporate Presentation Legal Disclaimers This presentation (the "Presentation") for RAPT Therapeutics, Inc. (the "Company," we," or "our") is made pursuant to Section 5(d) of the Securities Act of 1933 (the "Securities Act"), and is intended solely for investors that are "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) or institutions that are "accredited investors" (as defined in Rule 501 of Regulation D und ...